gonadotropin (hCG), alphafetoprotein (AFP), estriol, and inhibin multiple of the medians (MoMs) were collected, with abnormal levels defined as PAPP-A, 1 st trimester hCG, and estriol <5%ile, and AFP, 2 nd trimester hCG, and inhibin >95%ile for the cohort. Adverse outcomes were preterm delivery (PTD) < 37 and < 34 weeks gestation, small for gestational age (birthweight <10%ile), and pregnancy-associated hypertensive disease (preeclampsia, gestational hypertension, chronic hypertension with superimposed preeclampsia). Associations between abnormal analyte levels and outcomes, stratified by chorionicity, were calculated using chi-square or Fisher's exact test. RESULTS: Of 1060 twins delivered during the study interval, 480 (45.3%) had available analytes and met inclusion criteria -357 dichorionic/diamniotic (di/di) and 123 monochorionic/diamniotic (mono/di). Second trimester analytes were available for all while 249 (51.9%) and 167 (34.8%) women had PAPP-A and 1 st trimester beta-hCG respectively. Among di/di twins, elevated AFP (>3.70 MoM) was associated with increased PTD < 34 weeks (44.4 vs 16.5%, P ¼ 0.007) while elevated inhibin (>4.95 MoM) was associated with increased PTD < 37 weeks (94.1 vs 58.8%, P ¼ 0.004). For mono/di twins, elevated inhibin (>6.34 MoM) was associated with an increased PTD < 34 weeks (66.7 vs 24.8%, P¼0.04) and hypertensive disease (66.7 vs 21.4%, P¼0.03). There were no associations between adverse outcomes and other analytes. CONCLUSION: Elevated AFP and inhibin in twin pregnancies were associated with increased risks for PTD and pregnancy-associated hypertensive disease, though these associations differed by chorionicity. Such findings may contribute to the ability to identify twin pregnancies at increased risk for adverse outcomes.
128 Maternal and perinatal outcomes by gestational age with expectant management of full-term low -risk nulliparas
Alan T. Tita
Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network, Bethesda, MD OBJECTIVE: To compare risks of selected maternal and perinatal outcomes by completed week of gestation (GA) after 39 weeks in low-risk nulliparas undergoing expectant management (EM). STUDY DESIGN: Planned secondary analysis of a multicenter RCT of induction of labor (IOL) at 39 0/7 wks vs. EM until at least 40 5/7 wks but no later than 42 2/7 in low-risk nulliparas. Only women with nonanomalous neonates, who were randomized to and proceeded with EM, and who attained 39 0/7 wks were included in this analysis. Delivery GA was categorized by completed wk (39, 40 and 41) and by labor mode (spontaneous vs. medically-indicated). Outcomes were: a) maternal, including cesarean (CD) and an adverse composite outcome and b) perinatal outcomes, including a perinatal composite and NICU admission. Categorical variables were compared using Cochran-armitage trend or Chi-Square test, and continuous variables using a Jonckheere Terpstra test. For multivariable analysis we applied Poisson regression. RESULTS: A total of 2518 women met eligibility criteria for this analysis. Overall, 39% delivered at 39 wks, 44% at 40 wks (73% of all remaining) and 17% at 41 wks (Table 1) . Spontaneous labor occurred in 62.3%. The prevalence of medically-indicated delivery (including post-dates) increased with GA (Table 1) . Apart from postdates, hypertensive disorders of pregnancy (HDP) and PROM were the most common indications for delivery at 39 and 40 wks. Baseline characteristics differed by delivery GA (Table 1) , with the frequencies of Bishop score <5 and smoking, and the medians of age and BMI increasing with GA. The frequency of CD and the perinatal composite increased with increasing GA (Table 2) . Additionally, when comparing outcomes of deliveries at each GA vs. deliveries at subsequent GAs (aRR; 95% CI), CD was significantly lower at 39 wks (0.68; 0.58, 0.80) and 40 wks (0.64; 0.55, 0.76). CONCLUSION: Although most women undergoing EM after 39 weeks labor spontaneously, the likelihood of CD and adverse perinatal composite outcome increase with GA.
OBJECTIVE: Elevated inflammatory markers are associated with alterations in fetal development and adverse birth outcomes. Adequate sleep may be important for regulating inflammatory processes during pregnancy. The purpose of this analysis was to evaluate associations between inflammatory markers and self-reported sleep duration in pregnant women. STUDY DESIGN: Of 744 pregnant women enrolled in a multi-site prospective cohort study, 694 completed a survey on sleep quality and provided a serum sample between 12-20 weeks gestation. Sleep quality was evaluated using the validated Pittsburgh Sleep Quality Index, which includes a question on average hours of sleep per night. Levels of inflammatory markers, including TNFa, CRP, IL6, and IL10, were measured in maternal serum and log transformed. A ratio of IL6:IL10 was calculated as an indicator of pro-inflammatory and anti-inflammatory balance. Multivariable linear regression was used to evaluate the associations between each of the inflammatory markers and self-reported hours of sleep per night. RESULTS: Women reported an average of 6.9 hours of sleep per night (standard deviation: 1.6). In models adjusted for maternal age, race/ethnicity, education, income, BMI, marital status, smoking, and gestational age at assessment, a one-hour decrease in average amount of sleep per night was associated with increases in 
OBJECTIVE:
The AFE foundation in collaboration with Baylor College of Medicine has established an international AFE registry, using recently published diagnostic criteria for research reporting (Clark SL,2016 AJOG) . Given the theory of potential placental or fetal debris entering maternal circulation as a cause of AFE, we sought to investigate the relationship between abnormal placentation and occurrence of AFE. STUDY DESIGN: Charts of patients enrolled in the AFE registry between 2013 and 2017 were abstracted and women were classified as having AFE, unlikely to have an AFE, or indeterminate. Indeterminate cases were defined as those with incomplete records, or whose diagnosis remained uncertain after review. RESULTS: Of 145 currently enrolled patients, 115 had records available for review. Fifty-nine percent (68/115) were determined to have suffered an AFE, while 23% (26/115) were probable non-AFE, and 18% (21/115) were indeterminate. Seven percent (5/68) of women with an AFE had a placenta previa during the index pregnancy, compared to the established historical prevalence of 5 per 1,000
